诱导前列腺上皮细胞可塑性和入侵的p53-loss是由与瘤微环境的交叉声驱动的
Darya Yanushko1,2,3,4, Beatriz German Falcon1,2,3,4,5, Rana El Bizri1,2,3,4,6
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
Cell death & disease
|January 26, 2025
概括
前列腺癌细胞中的p53损失通过增加细胞可塑性和与癌症相关纤维细胞的沟通来促进侵袭和转移. 这突出了侵略性前列腺癌的新治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症转移 癌症转移
背景情况:
- 前列腺癌是一种异质性疾病,结果各不相同.
- 瘤抑制基因PTEN和TP53的突变与转移和不良预后有关.
- 不完全理解TP53损失诱导的攻击性和转移机制.
研究的目的:
- 调查Trp53缺乏在Pten-null前列腺癌进展中的作用.
- 阐明TP53损失诱导的细胞可塑性和转移背后的机制.
- 为了确定攻击性前列腺癌的潜在治疗点.
主要方法:
- 基因工程前列腺癌的小鼠模型.
- 单细胞转录和染色质可访问性分析.
- 组织学检查,体内实验和基于有机体的实验.
主要成果:
- 在Pten-null前列腺上皮细胞 (PECs) 中的Trp53缺乏会增强侵入性腺癌和转移.
- 鉴定出了一种独特的上皮细胞群体,具有诱导的Jak/Stat3信号和介质细胞特征.
- 这种细胞特征在高风险和转移性前列腺瘤中很普遍.
- PEC可塑性涉及与癌症相关纤维细胞 (CAFs) 的双向通信.
结论:
- 失 p53 驱动 PEC 和 CAF 之间的原始源交叉,促进前列腺癌的进展.
- 准这种交叉通话代表了攻击性前列腺癌的潜在治疗策略.
- 确定了细胞可塑性机制和Jak/Stat3信号作为潜在的漏洞.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


